Certara to Participate in Upcoming Investor Conferences
Certara (Nasdaq: CERT) said company management will participate in three investor conferences in November 2025 and that live webcasts and replays will be available on the company investor relations website.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Certara (Nasdaq: CERT) said company management will participate in three investor conferences in November 2025 and that live webcasts and replays will be available on the company investor relations website.
- UBS Global Healthcare Conference — Tuesday, November 11, 2025 at 2:00 PM ET
- Jefferies Global Healthcare Conference (London) — Tuesday, November 18, 2025 at 10:30 AM GMT
- Stephens Annual Investment Conference — Tuesday, November 18, 2025 at 1:00 PM CT
Live webcasts will stream at https://ir.certara.com and replays will be available for at least 90 days after each event.
Details
News Market Reaction – CERT
On Oct 31, the day this news came out, CERT closed 2.38% above the previous close.
Data tracked by StockTitan Argus for the Oct 31 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
- UBS Global Healthcare Conference
Date and Time: Tuesday, November 11th 2025 at 2:00PM ET
- Jefferies Global Healthcare Conference in London
Date and Time: Tuesday, November 18th 2025 at 10:30AM GMT
- Stephens Annual Investment Conference
Date and Time: Tuesday, November 18th 2025 at 1:00PM CT
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.